• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腺五肽和脾氨肽作为免疫调节剂。现状。

Thymopentin and splenopentin as immunomodulators. Current status.

作者信息

Singh V K, Biswas S, Mathur K B, Haq W, Garg S K, Agarwal S S

机构信息

Department of Immunology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India.

出版信息

Immunol Res. 1998;17(3):345-68. doi: 10.1007/BF02786456.

DOI:10.1007/BF02786456
PMID:9638477
Abstract

Splenopentin (SP-5, Arg-Lys-Glu-Val-Tyr) and thymopentin (TP-5, Arg-Lys-Asp-Val-Tyr) are synthetic immunomodulating peptides corresponding to the region 32-34 of a splenic product called splenin (SP) and the thymic hormone thymopoietin (TP), respectively. TP was originally isolated as a 5-kDa (49-amino acids) protein from bovine thymus while studying effects of the thymic extracts on neuromuscular transmission and was subsequently observed to affect T cell differentiation and function. TP I and II are two closely related polypeptides isolated from bovine thymus. A radioimmunoassay for TP revealed a crossreaction with a product found in spleen and lymph node. This product, named splenin, differs from TP only in position 34, aspartic acid for bovine TP and glutamic acid for bovine splenin and it was called TP III as well. Synthetic pentapeptides (TP-5) and (SP-5), reproduce the biological activities of TP and SP, respectively. It is now evident that various forms of TPs were created by proteolytic cleavage of larger proteins during isolation. cDNA clones have been isolated for three alternatively spliced mRNAs that encodes three distinct human T cell TPs. The immunomodulatory properties of TP, SP, TP-5, SP-5 and some of their synthetic analogs reported in the literature have been briefly reviewed.

摘要

脾五肽(SP - 5,精氨酸 - 赖氨酸 - 谷氨酸 - 缬氨酸 - 酪氨酸)和胸腺五肽(TP - 5,精氨酸 - 赖氨酸 - 天冬氨酸 - 缬氨酸 - 酪氨酸)是分别对应于一种名为脾素(SP)的脾脏产物的32 - 34区域和胸腺激素胸腺生成素(TP)的合成免疫调节肽。TP最初是在研究胸腺提取物对神经肌肉传递的影响时从牛胸腺中分离得到的一种5 kDa(49个氨基酸)的蛋白质,随后观察到它会影响T细胞的分化和功能。TP I和II是从牛胸腺中分离出的两种密切相关的多肽。一种针对TP的放射免疫测定显示与在脾脏和淋巴结中发现的一种产物有交叉反应。这种产物名为脾素,与TP仅在第34位不同,牛TP的第34位是天冬氨酸,牛脾素的第34位是谷氨酸,它也被称为TP III。合成五肽(TP - 5)和(SP - 5)分别重现了TP和SP的生物活性。现在很明显在分离过程中各种形式的TP是由较大蛋白质的蛋白水解切割产生的。已经分离出了编码三种不同人类T细胞TP的三种选择性剪接mRNA的cDNA克隆。本文简要综述了文献中报道的TP、SP、TP - 5、SP - 5及其一些合成类似物的免疫调节特性。

相似文献

1
Thymopentin and splenopentin as immunomodulators. Current status.胸腺五肽和脾氨肽作为免疫调节剂。现状。
Immunol Res. 1998;17(3):345-68. doi: 10.1007/BF02786456.
2
Contrasting biological activities of thymopoietin and splenin, two closely related polypeptide products of thymus and spleen.胸腺生成素和脾生素这两种胸腺与脾脏密切相关的多肽产物的生物活性对比。
Proc Natl Acad Sci U S A. 1984 May;81(9):2847-9. doi: 10.1073/pnas.81.9.2847.
3
Thymopoietin to thymopentin: experimental studies.胸腺生成素与胸腺五肽:实验研究
Surv Immunol Res. 1985;4 Suppl 1:1-10. doi: 10.1007/BF02919050.
4
Contrasting effects of thymopentin and splenopentin on the capacity of female mice to reject syngeneic male skin.
Transplantation. 1984 Jul;38(1):52-5. doi: 10.1097/00007890-198407000-00013.
5
Augmentation of human natural killer cells by splenopentin analogs.
FEBS Lett. 1993 Feb 8;317(1-2):93-5. doi: 10.1016/0014-5793(93)81498-o.
6
Immunoregulating peptides II. In vitro effects of TP5 analogs on E-rosette formation and cell division.免疫调节肽II。TP5类似物对E花环形成和细胞分裂的体外作用。
Immunopharmacol Immunotoxicol. 1987;9(1):1-18. doi: 10.3109/08923978709035198.
7
Stimulation of IL-2 production and CD2R expression by splenopentin analogs.
Int J Immunopharmacol. 1997 Jun;19(6):341-5. doi: 10.1016/s0192-0561(97)00032-5.
8
The effect of TP-5 and its analogs on skin grafts in mice.TP-5及其类似物对小鼠皮肤移植的影响。
J Immunopharmacol. 1985;7(1):67-78.
9
Structural requirements for the biological activity of thymopentin analogs.胸腺五肽类似物生物活性的结构要求
Arch Biochem Biophys. 1985 Oct;242(1):248-55. doi: 10.1016/0003-9861(85)90499-0.
10
In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production.
Clin Immunol Immunopathol. 1987 Feb;42(2):151-9. doi: 10.1016/0090-1229(87)90002-x.

引用本文的文献

1
Thymopentapeptide Affects T-Cell Subsets by Modulating the Flora of the Skin Surface to Alleviate Psoriasis.胸腺五肽通过调节皮肤表面菌群来影响 T 细胞亚群,从而缓解银屑病。
Drug Des Devel Ther. 2024 Jul 4;18:2775-2791. doi: 10.2147/DDDT.S448550. eCollection 2024.
2
Cellular Uptake and Transport Mechanism Investigations of PEGylated Niosomes for Improving the Oral Delivery of Thymopentin.用于改善胸腺五肽口服递送的聚乙二醇化脂质体的细胞摄取和转运机制研究
Pharmaceutics. 2024 Mar 14;16(3):397. doi: 10.3390/pharmaceutics16030397.
3
Mechanism and clinical application of thymosin in the treatment of lung cancer.

本文引用的文献

1
Phase variation in the modulation of the human immune response.
Immunol Today. 1983 Aug;4(8):213-4. doi: 10.1016/0167-5699(83)90028-2.
2
Stimulation of IL-2 production and CD2R expression by splenopentin analogs.
Int J Immunopharmacol. 1997 Jun;19(6):341-5. doi: 10.1016/s0192-0561(97)00032-5.
3
Upregulation of HLA class-I gene transcription in K562 cells by analogs of splenopentin (SP-5).
Biochem Mol Biol Int. 1997 Mar;41(3):521-8. doi: 10.1080/15216549700201541.
4
Topical thymopentin therapy in HIV positive patients with recurrent oral candidiasis: a pilot study.
New Microbiol. 1996 Oct;19(4):351-5.
胸腺素治疗肺癌的机制及临床应用。
Front Immunol. 2023 Aug 28;14:1237978. doi: 10.3389/fimmu.2023.1237978. eCollection 2023.
4
Thymopentin-Mediated Inhibition of Cancer Stem Cell Stemness Enhances the Cytotoxic Effect of Oxaliplatin on Colon Cancer Cells.胸腺五肽介导的对癌症干细胞干性的抑制增强了奥沙利铂对结肠癌细胞的细胞毒性作用。
Front Pharmacol. 2022 Feb 15;13:779715. doi: 10.3389/fphar.2022.779715. eCollection 2022.
5
Thymodepressin-Unforeseen Immunosuppressor.胸腺肽——意料之外的免疫抑制剂。
Molecules. 2021 Oct 29;26(21):6550. doi: 10.3390/molecules26216550.
6
Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses.靶向 TLR2 受体的新型胸腺五肽衍生肽调节免疫反应。
Front Immunol. 2021 May 27;12:620494. doi: 10.3389/fimmu.2021.620494. eCollection 2021.
7
Design and Immunological Evaluation of a Hybrid Peptide as a Potent TLR2 Agonist by Structure-Based Virtual Screening.基于结构的虚拟筛选设计并免疫评估一种作为强效TLR2激动剂的杂合肽
Front Cell Dev Biol. 2021 Feb 11;9:620370. doi: 10.3389/fcell.2021.620370. eCollection 2021.
8
C-Terminal Amination of a Cationic Anti-Inflammatory Peptide Improves Bioavailability and Inhibitory Activity Against LPS-Induced Inflammation.一种阳离子抗炎肽的C末端胺化可提高生物利用度并增强对脂多糖诱导炎症的抑制活性。
Front Immunol. 2021 Feb 5;11:618312. doi: 10.3389/fimmu.2020.618312. eCollection 2020.
9
Peptides: Prospects for Use in the Treatment of COVID-19.肽:在 COVID-19 治疗中的应用前景。
Molecules. 2020 Sep 24;25(19):4389. doi: 10.3390/molecules25194389.
10
Impact of Yeast Expressed Hybrid Peptide CATH-2TP5 as a Prophylactic Measure Toward Sepsis and Inflammation.酵母表达的杂交肽CATH-2TP5作为脓毒症和炎症预防措施的作用
Front Bioeng Biotechnol. 2020 Jun 3;8:454. doi: 10.3389/fbioe.2020.00454. eCollection 2020.
5
The characterization and localization of the mouse thymopoietin/lamina-associated polypeptide 2 gene and its alternatively spliced products.小鼠胸腺生成素/核纤层相关多肽2基因及其可变剪接产物的特征与定位
Genome Res. 1996 May;6(5):361-70. doi: 10.1101/gr.6.5.361.
6
Synthesis of [Phe(4F)3]thymopoietin II and examination of its immunological effect on the impaired blastogenic response of T-lymphocytes of uremic patients.
Bioorg Med Chem. 1995 Oct;3(10):1369-75. doi: 10.1016/0968-0896(95)00121-v.
7
Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO beta to rat lamin-associated polypeptide 2.人类胸腺生成素(TMPO)基因的结构与定位以及人类TMPOβ与大鼠核纤层相关多肽2的关系
Genomics. 1995 Jul 20;28(2):198-205. doi: 10.1006/geno.1995.1131.
8
The effect of splenopentin (DA SP-5) on in vitro myelopoiesis and on AZT-induced bone marrow toxicity.
Int J Immunopharmacol. 1993 Apr;15(3):269-73. doi: 10.1016/0192-0561(93)90035-w.
9
Augmentation of human natural killer cells by splenopentin analogs.
FEBS Lett. 1993 Feb 8;317(1-2):93-5. doi: 10.1016/0014-5793(93)81498-o.
10
Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation.通过免疫调节成功恢复体外循环后细胞介导的免疫反应。
J Thorac Cardiovasc Surg. 1993 Jan;105(1):15-24.